A variety of strategies have been developed to prevent and reduce the occurrence of OHSS, the most effective being the use of GnRHa instead of the traditional hCG to trigger final oocyte maturation in GnRH antagonist cycles [24, 25]. The gene discussed is GNRH1; the disease is ovarian hyperstimulation syndrome.